Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Shizhang Wei"'
Autor:
Xin Wang, Lisheng Chen, Lei Chang, Yong He, Tingting He, Ruilin Wang, Shizhang Wei, Manyi Jing, Xuelin Zhou, Haotian Li, Yanling Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Background: Gastric ulcers (GUs) are prevalent digestive disorders worldwide. Wuzhuyu Decoction (WZYT) is a traditional Chinese medicine that has been employed for centuries to alleviate digestive ailments like indigestion and vomiting. This study ai
Externí odkaz:
https://doaj.org/article/5b57862afdfb4c7f876472a68a423705
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Primary biliary cirrhosis (PBC) is a chronic cholestatic immune liver disease characterized by persistent cholestasis, interlobular bile duct damage, portal inflammation, liver fibrosis, eventual cirrhosis, and death. Existing clinical and animal stu
Externí odkaz:
https://doaj.org/article/cf8092fc61024c349ab6c99d9209152d
Autor:
Shuying Xie, Shizhang Wei, Xiao Ma, Ruilin Wang, Tingting He, Zhao Zhang, Ju Yang, Jiawei Wang, Lei Chang, Manyi Jing, Haotian Li, Xuelin Zhou, Yanling Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Hereditary cholestatic liver disease caused by a class of autosomal gene mutations results in jaundice, which involves the abnormality of the synthesis, secretion, and other disorders of bile acids metabolism. Due to the existence of a variety of gen
Externí odkaz:
https://doaj.org/article/ac710df92fad42c3b0b8b637cbf60da9
Autor:
Shizhang Wei, Tingting He, Xu Zhao, Manyi Jing, Haotian Li, Lisheng Chen, Ruimao Zheng, Yanling Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Farnesoid X receptor (FXR) is a key metabolic target of bile acids (BAs) and is also a target for drugs against several liver diseases. However, the contribution of FXR in the pathogenesis of cholestasis is still not fully understood. The
Externí odkaz:
https://doaj.org/article/9244b1fb76004527a36cfc57b5e363aa
Autor:
Tao Yang, Xiao Ma, Ruilin Wang, Honghong Liu, Shizhang Wei, Manyi Jing, Haotian Li, Yanling Zhao
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 6, Pp 764-778 (2022)
Aims: The potential signaling pathways and core genes in ulcerative colitis (UC) were investigated in this study. Furthermore, potential mechanisms of BBR in treating UC were also explored. Methods: Expression profiling by array of UC patients were o
Externí odkaz:
https://doaj.org/article/d9592d76c8954f71ba786b837c1dfcce
Autor:
Lisheng Chen, Shizhang Wei, Yong He, Xin Wang, Tingting He, Aozhe Zhang, Manyi Jing, Haotian Li, Ruilin Wang, Yanling Zhao
Publikováno v:
Pharmaceuticals, Vol 16, Iss 9, p 1308 (2023)
Chronic gastritis (CG) is a common clinical digestive system disease, which is not easyily cured and is prone to recurrence. Traditional Chinese medicine (TCM) plays a significant role in the treatment of CG and has attracted increasing attention for
Externí odkaz:
https://doaj.org/article/382fbca3b1f440c59b5be6dd42a490aa
Autor:
Xiao Ma, Shuying Xie, Ruilin Wang, Zhongxia Wang, Manyi Jing, Haotian Li, Shizhang Wei, Honghong Liu, Jianyu Li, Qingyong He, Yanling Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: Chronic nonatrophic gastritis (CNG) is the most common digestive disease. In China, Zuojin pill (ZJP) is considered an effective medicine formula for CNG. However, its efficacy and mechanism have never been explored. In order to understand
Externí odkaz:
https://doaj.org/article/66bd8c57a9b04f5bb7a891d238f39efd
Autor:
Qichao Hu, Shizhang Wei, Jianxia Wen, Wenwen Zhang, Yinxiao Jiang, Caiyan Qu, Junbao Xiang, Yanling Zhao, Xi Peng, Xiao Ma
Publikováno v:
BioData Mining, Vol 13, Iss 1, Pp 1-14 (2020)
Abstract Background Non-alcoholic fatty liver (NAFLD) is a chronic disease worldwide, which poses a huge threat to human health. Xiaochaihu decoction is a well-known traditional Chinese medicine prescription. It has been proven effective in treating
Externí odkaz:
https://doaj.org/article/8d34f66beabc46bd8617202791b86f76
Autor:
Jianxia Wen, Ruilin Wang, Honghong Liu, Yuling Tong, Shizhang Wei, Xuelin Zhou, Haotian Li, Manyi Jing, Min Wang, Yanling Zhao
Publikováno v:
Chinese Medicine, Vol 15, Iss 1, Pp 1-17 (2020)
Abstract The Corona Virus Disease 2019 (COVID-19) is an acute respiratory infectious disease. At present, COVID-19 has no specific therapeutic drugs, and the main clinical treatment is symptomatic treatment and control of complications. On March 5, 2
Externí odkaz:
https://doaj.org/article/f20b227c5b634c6b9b189fc169a3c407
Autor:
Junqi Zhao, Fangling Zhang, Xiaolin Xiao, Zhao Wu, Qichao Hu, Yinxiao Jiang, Wenwen Zhang, Shizhang Wei, Xiao Ma, Xiaomei Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Tripterygium hypoglaucum (Lévl.) Hutch (THH) is believed to play an important role in health care and disease treatment according to traditional Chinese medicine. Moreover, it is also the representative of medicine with both significant efficacy and
Externí odkaz:
https://doaj.org/article/e8ba9cf48e2b44ceb915c3981d4ea8b8